article thumbnail

The 2024 Controlled Substance Assessment Quiz

OctariusRx

The 2024 controlled substance assessment quiz is about to be released! This is our annual competency assessment focused on controlled substances and regulatory compliance. The quiz focuses on some of the basic elements managing controlled substances. How are you assessing your staff?

article thumbnail

Corresponding Responsibility of Pharmacies, DEA to Uphold Controlled Substances Act | ASPL 2024

Drug Topics

Joel Ferre, JD, Assistant United States Attorney in Utah, led a discussion covering the DEA and pharmacies’ roles in reporting red flags when dispensing medication.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Is gabapentin a controlled substance?

The Checkup by Singlecare

At this time, gabapentin isn’t recognized as a controlled substance on the federal level. However, several states have passed laws to classify it as a Schedule V controlled substance. RELATED: What is Gabapentin: Uses, Warnings & Interactions Is gabapentin a controlled substance?

article thumbnail

Preparation, Cooperation Keys to Surviving a DEA Inspection | NCPA 2024

Drug Topics

The Drug Enforcement Administration gives controlled substance licenses, and can just as easily take them away.

article thumbnail

The 2024 USP 800 Assessment Quiz

OctariusRx

The 2024 version of the OctariusRx USP 800 assessment quiz is about to be released! Earlier this year, we discussed Nursing Medication Calculations, Medication safety and Controlled Substances to help your staff hone their skills and let you assess their abilities. Contact us for assistance.

article thumbnail

DEA extends pandemic rules for telehealth prescribing through 2024 as agency irons out new policies

Fierce Healthcare

The Drug Enforcement Administration (DEA) said Friday it will extend telehealth flexibilities that enable clinicians to virtually prescribe controlled medications to their patients through 2024 as | The DEA announced Friday that it is extending pandemic rules for prescribing controlled substances via telemedicine through the end of next year.

article thumbnail

STAT+: Key lawmakers pressure Biden to preserve telehealth prescribing of effective addiction treatment

STAT

urged the DEA to continue allowing health providers to prescribe buprenorphine, a controlled substance used to treat opioid addiction, without requiring an in-person visit.    Prior to the Covid-19 pandemic, any patient who needed a controlled substance was required to be examined in person before receiving a prescription.